Ttbio Corp.

Taipei Exchange 6493.TWO

Ttbio Corp. Gross Profit Margin for the year ending December 31, 2023: 24.65%

Ttbio Corp. Gross Profit Margin is 24.65% for the year ending December 31, 2023, a -15.72% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Ttbio Corp. Gross Profit Margin for the year ending December 31, 2022 was 29.25%, a -1.20% change year over year.
  • Ttbio Corp. Gross Profit Margin for the year ending December 31, 2021 was 29.61%, a 8.38% change year over year.
  • Ttbio Corp. Gross Profit Margin for the year ending December 31, 2020 was 27.32%, a -4.94% change year over year.
  • Ttbio Corp. Gross Profit Margin for the year ending December 31, 2019 was 28.74%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Taipei Exchange: 6493.TWO

Ttbio Corp.

CEO Shu Rong Yang
IPO Date Jan. 8, 2015
Location
Headquarters No. 07, 6th Road Industry Park
Employees 101
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email